Fortive consensus picture steady, shares tracked against S&P 500 peers
Published on 06/25/2026 at 15:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-25, 15:13.
Fortive Corp (US34959J1088) currently carries a predominantly positive analyst consensus, with most brokers rating the stock Buy and seeing scope for further upside. The NYSE-listed S&P 500 member is widely compared with industrial peers such as Danaher and Emerson, according to recent analyst overviews from MarketScreener and other platforms.
What recent analyst data show
According to a recent consensus snapshot on MarketScreener, more than half of the analysts covering Fortive rate the stock at Buy or Outperform, with the remainder largely at Hold and only isolated Sell ratings. The average 12-month price target in that compilation stands in the mid-80s USD per share range, implying double-digit percentage upside versus the latest trading levels, even though individual targets from houses such as Goldman Sachs, JPMorgan or Morgan Stanley differ in detail and time horizon.
Several large banks covering the US industrial and instrumentation sector emphasize Fortive's exposure to recurring revenue through software and service models, which they see as supportive for valuation compared with more cyclical hardware-focused players. In these notes, Fortive is frequently discussed alongside Danaher, Roper Technologies and Emerson Electric as part of a group of diversified, acquisition-driven industrial technology companies that have shifted toward higher-margin, asset-light businesses.
Positioning among industrial technology peers
Fortive's analyst coverage often highlights the company's portfolio of test and measurement, industrial automation and healthcare equipment assets, which are seen as benefiting from long-term investment trends in factory automation, digitization and process efficiency. When brokers compare valuation multiples across the group, Fortive's forward earnings multiple typically trades at a modest discount or in line with Danaher and Roper, but at a premium to more traditional multi-industry names such as Emerson or Honeywell, reflecting its higher software and recurring revenue share.
Research houses point out that Fortive's strategy of bolt-on acquisitions, portfolio pruning and increased focus on software-enabled workflows is designed to sustain mid-single to high-single-digit organic growth over the cycle. This strategy is viewed as supportive of steady margin expansion and cash generation, which in turn provides room for further acquisitions, share repurchases or balance-sheet strengthening, depending on management priorities and market conditions discussed in quarterly calls and investor presentations.
All news and analysis on the Fortive Corp shares
Track further corporate disclosures and market commentary for Fortive, including consensus changes, quarterly figures and sector comparisons.
The product mix behind earnings power
Fortive generates revenue from a portfolio of industrial technology businesses spanning test and measurement instruments, field solutions, sensing and health care technologies, among others. Representative products include Fluke-branded industrial multimeters and process calibration tools, Tektronix oscilloscopes and signal analyzers, and advanced sensing solutions used across manufacturing, energy and medical applications.
Where the stock trades today
Fortive shares trade on the NYSE in US dollars; the latest available quotes place the stock in the mid-70s USD per share range in recent sessions, in line with large-cap US industrial technology peers in the S&P 500.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
